Merck’s $8 billion cancer vaccine faces first U.S. jury trial
- Posted on January 27, 2025
- By Fortune
- 1 Views
Merck’s $8 billion cancer vaccine faces first U.S. jury trial
Jurors will weigh whether Merck withheld side-effect reports and launched misleading marketing campaigns to turn the drug into a blockbuster product.
